Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Lal

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Southeast Asian Journal of Tropical Medicine and Public Health|June 15, 2006
Visceral leishmaniasis and tuberculosis in patients with HIV co-infectionV N R Das, K Pandey, N Kumar, et al.
The Journal of Communicable Diseases|July 8, 2009
Clinical and laboratory comparison of different brands of amphotericin B used for the treatment of Kala-azar: an observational studyShyam Narayan, A K Gupta, K Singh Subhankar, et al.
Annals of Tropical Medicine and Parasitology|March 6, 2008
HIV infection, visceral leishmaniasis and Guillain-Barré syndrome in the same patient: a case reportN Kumar, K Pandey, V N R Das, et al.
Annals of Tropical Medicine and Parasitology|September 20, 2007
Miltefosine in the treatment of a case of visceral leishmaniasis with renal dysfunctionN Kumar, K Pandey, V N R Das, et al.
Annals of Tropical Medicine and Parasitology|November 22, 2005
HIV-1 infection, visceral leishmaniasis, Koch's chest and tuberculous meningitis in the same patient--a case reportK Pandey, P K Sinha, V N R Das, et al.
Journal of Vector Borne Diseases|December 3, 2020
Magnitude of unreported kala-azar cases in a highly endemic district of Bihar, India: A positive impact of Indian elimination programmeN A Siddiqui, K Pandey, V N R Das, et al.
The Journal of Infection|November 5, 2005
Visceral leishmaniasis (kala-azar)--the Bihar (India) perspectiveP K Sinha, A Ranjan, V P Singh, et al.
Infection|July 11, 2015
Hypertriglyceridemia: a possible diagnostic marker of disease severity in visceral leishmaniasisC S Lal, R B Verma, N Verma, et al.
The British Journal of Dermatology|October 27, 2016
Safety and efficacy of a combination of paromomycin and miltefosine for two vs. three courses in patients with post-kala-azar dermal leishmaniasis: an observational pilot studyK Pandey, B Pal, V N R Das, et al.
The American Journal of Tropical Medicine and Hygiene|September 11, 2007
Wilson disease with visceral leishmaniasis: an extremely uncommon presentationK Pandey, P K Sinha, V N R Das, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Southeast Asian Journal of Tropical Medicine and Public Health|June 15, 2006
Visceral leishmaniasis and tuberculosis in patients with HIV co-infectionV N R Das, K Pandey, N Kumar, et al.
The Journal of Communicable Diseases|July 8, 2009
Clinical and laboratory comparison of different brands of amphotericin B used for the treatment of Kala-azar: an observational studyShyam Narayan, A K Gupta, K Singh Subhankar, et al.
Annals of Tropical Medicine and Parasitology|March 6, 2008
HIV infection, visceral leishmaniasis and Guillain-Barré syndrome in the same patient: a case reportN Kumar, K Pandey, V N R Das, et al.
Annals of Tropical Medicine and Parasitology|September 20, 2007
Miltefosine in the treatment of a case of visceral leishmaniasis with renal dysfunctionN Kumar, K Pandey, V N R Das, et al.
Annals of Tropical Medicine and Parasitology|November 22, 2005
HIV-1 infection, visceral leishmaniasis, Koch's chest and tuberculous meningitis in the same patient--a case reportK Pandey, P K Sinha, V N R Das, et al.
Journal of Vector Borne Diseases|December 3, 2020
Magnitude of unreported kala-azar cases in a highly endemic district of Bihar, India: A positive impact of Indian elimination programmeN A Siddiqui, K Pandey, V N R Das, et al.
The Journal of Infection|November 5, 2005
Visceral leishmaniasis (kala-azar)--the Bihar (India) perspectiveP K Sinha, A Ranjan, V P Singh, et al.
Infection|July 11, 2015
Hypertriglyceridemia: a possible diagnostic marker of disease severity in visceral leishmaniasisC S Lal, R B Verma, N Verma, et al.
The British Journal of Dermatology|October 27, 2016
Safety and efficacy of a combination of paromomycin and miltefosine for two vs. three courses in patients with post-kala-azar dermal leishmaniasis: an observational pilot studyK Pandey, B Pal, V N R Das, et al.
The American Journal of Tropical Medicine and Hygiene|September 11, 2007
Wilson disease with visceral leishmaniasis: an extremely uncommon presentationK Pandey, P K Sinha, V N R Das, et al.
Pageof 3